We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
+17.02%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$1.39B
AUM Growth
+$182M
(+15%)
Cap. Flow
+$29.2M
Cap. Flow
% of AUM
2.11%
Top 10 Holdings %
Top 10 Hldgs %
21.32%
Holding
144
New
11
Increased
32
Reduced
89
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STMP
Stamps.com, Inc.
STMP
|
+$18.7M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$14.3M |
| 3 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
+$12.7M |
| 4 |
QUOT
Quotient Technology Inc
QUOT
|
+$10.1M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$20.9M |
| 2 |
LOGM
LogMein, Inc.
LOGM
|
+$17.8M |
| 3 |
MaxLinear
MXL
|
+$15M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
+$7.78M |
| 5 |
Chegg
CHGG
|
+$7.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.71% |
| 2 | Industrials | 18.01% |
| 3 | Technology | 15.51% |
| 4 | Communication Services | 12.14% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INXN
1
DELISTED
Interxion Holding N.V.
INXN
| $43.8M | 3.16% |
656,949
-3,676
| -0.6% | -$228K |
|
|
QUOT
2
DELISTED
Quotient Technology Inc
QUOT
| $42.7M | 3.08% |
4,329,615
+980,478
| +29% | +$10.1M |
|
3
Cerus
CERS
$431M
| $35.8M | 2.58% |
5,740,291
-14,941
| -0.3% | -$90.7K |
|
|
4
MaxLinear
MXL
$6.06B
| $27.9M | 2.01% |
1,091,120
-684,080
| -39% | -$15M |
|
|
IVC
5
DELISTED
Invacare Corporation
IVC
| $26.6M | 1.92% |
3,177,507
+73,599
| +2% | +$530K |
|
|
6
Ligand Pharmaceuticals
LGND
$5.76B
| $26.4M | 1.9% |
336,346
+188,896
| +128% | +$14.3M |
|
|
IPHI
7
DELISTED
INPHI CORPORATION
IPHI
| $24.9M | 1.8% |
570,017
-163,422
| -22% | -$6.5M |
|
8
Evolent Health
EVH
$348M
| $23.1M | 1.66% |
1,832,893
+94,887
| +5% | +$1.5M |
|
|
EFII
9
DELISTED
Electronics for Imaging
EFII
| $22.3M | 1.61% |
829,691
-2,008
| -0.2% | -$52.8K |
|
10
OneSpan
OSPN
$574M
| $22.3M | 1.61% |
1,160,028
-93,320
| -7% | -$1.59M |
|
11
Iridium Communications
IRDM
$5.02B
| $22.3M | 1.61% |
842,863
-227,777
| -21% | -$4.9M |
|
12
Pacira BioSciences
PCRX
$1.04B
| $21.5M | 1.55% |
564,576
+28,382
| +5% | +$1.11M |
|
|
WAGE
13
DELISTED
WageWorks, Inc.
WAGE
| $21.4M | 1.54% |
566,691
+41,078
| +8% | +$1.34M |
|
|
MDCO
14
DELISTED
Medicines Co
MDCO
| $21.2M | 1.53% |
760,225
-2,929
| -0.4% | -$69K |
|
15
Healthcare Services Group
HCSG
$1.6B
| $20.6M | 1.48% |
622,953
+159,160
| +34% | +$6.1M |
|
|
SNCR
16
DELISTED
Synchronoss Technologies
SNCR
| $19.7M | 1.42% |
359,328
-1,705
| -0.5% | -$111K |
|
17
MasTec
MTZ
$20.8B
| $19.4M | 1.4% |
403,846
-2,385
| -0.6% | -$107K |
|
|
WMGI
18
DELISTED
Wright Medical Group Inc
WMGI
| $19M | 1.37% |
604,741
-91,131
| -13% | -$2.77M |
|
|
ADSW
19
DELISTED
Advanced Disposal Services Inc
ADSW
| $18.3M | 1.32% |
654,809
-1,772
| -0.3% | -$46.1K |
|
|
CVSA
20
Covista Inc
CVSA
$4.25B
| $18.2M | 1.31% |
392,637
+34,501
| +10% | +$1.66M |
|
21
PTC Therapeutics
PTCT
$5.64B
| $17.6M | 1.27% |
467,537
+89,863
| +24% | +$3.02M |
|
|
RCM
22
DELISTED
R1 RCM Inc. Common Stock
RCM
| $17.2M | 1.24% |
1,779,374
+94,411
| +6% | +$854K |
|
23
Gogo Inc
GOGO
$565M
| $16.9M | 1.22% |
3,763,459
+302,573
| +9% | +$1.26M |
|
|
NGHC
24
DELISTED
National General Holdings Corp
NGHC
| $16.7M | 1.21% |
704,484
-2,741
| -0.4% | -$67.5K |
|
|
INFN
25
DELISTED
Infinera Corporation Common Stock
INFN
| $15.6M | 1.12% |
3,592,022
-16,211
| -0.4% | -$74.8K |
|
Similar funds
BAC
AVC
OWD
PP
WWM
JA
PL
EA
Elk Creek Partners's Q1 2019 Portfolio in Review
As of Q1 2019, Elk Creek Partners held 144 positions worth $1.39B, up 15% from $1.21B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Elk Creek Partners's Q1 2019 filing shows 11 new, 32 increased, 89 reduced and 12 closed positions. Its largest new stake was Stamps.com, Inc.: 132,819 shares worth $10.8M. The largest sale was Intercept Pharmaceuticals, Inc., an estimated $20.9M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.
- Elk Creek Partners's largest Q1 2019 buy was Stamps.com, Inc.: 132,819 shares worth $10.8M.
- Elk Creek Partners added most to Ligand Pharmaceuticals in Q1 2019, an estimated $14.3M increase.
- Elk Creek Partners's biggest Q1 2019 reduction was MaxLinear, cutting an estimated $15M.
- Elk Creek Partners fully exited Intercept Pharmaceuticals, Inc. in Q1 2019, selling an estimated $20.9M.
- Elk Creek Partners's ten largest holdings make up 21% of its $1.39B portfolio in Q1 2019.
- Elk Creek Partners opened 11 new positions and closed 12 in Q1 2019.
- Elk Creek Partners's portfolio value rose 15% quarter-over-quarter to $1.39B.
Based on Elk Creek Partners's 13F filing for Q1 2019, filed 10 May 2019.